Teruravone
泰瑞拉奉
Report date: 2023/09/20 20:05:32
NME
Base Information
Drug NameTeruravone
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSinobioway Biomedicine Co LtdQingdao Huanghai Pharmaceutical Co LtdNanjing Zhongrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesNanjing Zhongrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A